- Home
- TXMD
TXMD
TherapeuticsMD Inc.
as 04-01-2025 4:00pm EST
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | BOCA RATON |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 56.2K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.19 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.70 - $2.44 | Next Earning Date: | 05-09-2025 |
| Revenue: | $1,761,000 | Revenue Growth: | 35.25% |
| Revenue Growth (this year): | 605.07% | Revenue Growth (next year): | 1.11% |
Latest TherapeuticsMD Inc. News
TXMD Breaking Stock News: Dive into TXMD Ticker-Specific Updates for Smart Investing
Simply Wall St.
3 days ago
TherapeuticsMD Full Year 2024 Earnings: US$0.20 loss per share (vs US$0.74 loss in FY 2023)
Business Wire
5 days ago
TherapeuticsMD Announces Full Year 2024 Financial Results
Simply Wall St.
3 months ago
3 Promising US Penny Stocks With Over $9M Market Cap
Simply Wall St.
5 months ago
TherapeuticsMD Third Quarter 2024 Earnings: US$0.049 loss per share (vs US$0.13 loss in 3Q 2023)
Associated Press Finance
5 months ago
TherapeuticsMD: Q3 Earnings Snapshot
Business Wire
5 months ago
TherapeuticsMD Announces Third Quarter 2024 Financial Results
Associated Press Finance
8 months ago
TherapeuticsMD: Q2 Earnings Snapshot
Business Wire
8 months ago
TherapeuticsMD Announces Second Quarter 2024 Financial Results
Compare TXMD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TXMD TherapeuticsMD Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.